Giorgio Ivan Russo1, Timo Soeterik2, Ignacio Puche-Sanz3, Giuseppe Broggi4, Arturo Lo Giudice5, Cosimo De Nunzio6, Riccardo Lombardo6, Giancarlo Marra7, Giorgio Gandaglia8. 1. Urology Section, University of Catania, Catania, Italy. giorgioivan1987@gmail.com. 2. Department of Urology, St Antonius Hospital, Utrecht, The Netherlands. 3. Hospital Universitario Virgen de las Nieves (HUVN). Department of Urology. Instituto de Investigación Biosanitaria ibs. GRANADA, Granada, Spain. 4. Department of Medical and Surgical Sciences and Advanced Technologies "G.F. Ingrassia", Catania, Italy. 5. Urology Section, University of Catania, Catania, Italy. 6. Department of Urology, "Sant'Andrea" Hospital, "La Sapienza" University, Rome, Italy. 7. Department of Surgical Sciences, University of Turin and Città della Salute e della Scienza, Turin, Italy. 8. Unit of Urology/Division of Oncology, IRCCS Ospedale San Raffaele, Milan, Italy.
Abstract
BACKGROUND: Changes applied to the Prostate cancer (PCa) histopathology grading, where patients with cribriform patterns (CP) may be categorized as grade group 2 and could hypothetically be surveilled. However, CP has been associated with worse oncological outcomes. The aim of our study is to systematically review and meta-analyze the available evidence on CP in PCa patients. METHODS: This analysis was registered on PROSPERO (CRD42022298473). We performed a systematic literature search of PubMed, EMBASE and Scopus using Medical Subject Headings (MeSH) indexes, keyword searches, and publication types until December 2021. The search terms included: "prostate", "prostate cancer" and "cribriform". We also searched reference lists of relevant articles. Eligible studies included published journal articles that provided quantitative data on the association between cribriform patterns at radical prostatectomy and the presence of extra-prostatic extension (EPE), seminal vesicle invasion (SVI), positive surgical margins (PSM), biochemical recurrence (BCR) or cancer specific mortality (CSM). RESULTS: Overall, 31 studies were included for the quantitative analysis. All articles have been published during a span of 11 years (2011-2022) with a mean month of follow-up of 62.87 months. The mean quality of these studies, assessed with the Newcastle Ottawa Scale was 6.27. We demonstrated that CP was associated with greater risk of EPE (odds ratio [OR] 1.96; P < 0.0001), SVI (OR: 2.89; p < 0.01), and PSM (OR: 1.88; p < 0.0007). Our analyses showed that CP was associated with greater risk of BCR (hazard ratio [HR]: 2.14; p < 0.01) and of CSM (HR: 3.30, p < 0.01). CONCLUSION: The presence of CP is associated with adverse pathology at radical prostatectomy and worse biochemical recurrence and cancer specific mortality. These results highlight the importance of a better pathologic report of CP to advise clinician for a strict follow-up in PCa patients.
BACKGROUND: Changes applied to the Prostate cancer (PCa) histopathology grading, where patients with cribriform patterns (CP) may be categorized as grade group 2 and could hypothetically be surveilled. However, CP has been associated with worse oncological outcomes. The aim of our study is to systematically review and meta-analyze the available evidence on CP in PCa patients. METHODS: This analysis was registered on PROSPERO (CRD42022298473). We performed a systematic literature search of PubMed, EMBASE and Scopus using Medical Subject Headings (MeSH) indexes, keyword searches, and publication types until December 2021. The search terms included: "prostate", "prostate cancer" and "cribriform". We also searched reference lists of relevant articles. Eligible studies included published journal articles that provided quantitative data on the association between cribriform patterns at radical prostatectomy and the presence of extra-prostatic extension (EPE), seminal vesicle invasion (SVI), positive surgical margins (PSM), biochemical recurrence (BCR) or cancer specific mortality (CSM). RESULTS: Overall, 31 studies were included for the quantitative analysis. All articles have been published during a span of 11 years (2011-2022) with a mean month of follow-up of 62.87 months. The mean quality of these studies, assessed with the Newcastle Ottawa Scale was 6.27. We demonstrated that CP was associated with greater risk of EPE (odds ratio [OR] 1.96; P < 0.0001), SVI (OR: 2.89; p < 0.01), and PSM (OR: 1.88; p < 0.0007). Our analyses showed that CP was associated with greater risk of BCR (hazard ratio [HR]: 2.14; p < 0.01) and of CSM (HR: 3.30, p < 0.01). CONCLUSION: The presence of CP is associated with adverse pathology at radical prostatectomy and worse biochemical recurrence and cancer specific mortality. These results highlight the importance of a better pathologic report of CP to advise clinician for a strict follow-up in PCa patients.
Authors: Dominique Trudel; Michelle R Downes; Jenna Sykes; Ken J Kron; John Trachtenberg; Theodorus H van der Kwast Journal: Eur J Cancer Date: 2014-04-03 Impact factor: 9.162
Authors: Alena Böker; Markus A Kuczyk; Mario W Kramer; Axel S Merseburger; Katharina Krüger; Florian Imkamp; Christoph A von Klot Journal: Adv Ther Date: 2016-11-26 Impact factor: 3.845
Authors: Charlotte F Kweldam; Mark F Wildhagen; Ewout W Steyerberg; Chris H Bangma; Theodorus H van der Kwast; Geert J L H van Leenders Journal: Mod Pathol Date: 2014-09-05 Impact factor: 7.842
Authors: Habiba Elfandy; Joshua Armenia; Filippo Pederzoli; Eli Pullman; Nelma Pertega-Gomes; Nikolaus Schultz; Kartik Viswanathan; Aram Vosoughi; Mirjam Blattner; Konrad H Stopsack; Giorgia Zadra; Kathryn L Penney; Juan Miguel Mosquera; Svitlana Tyekucheva; Lorelei A Mucci; Christopher Barbieri; Massimo Loda Journal: Mol Cancer Res Date: 2018-10-17 Impact factor: 5.852
Authors: Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher Journal: PLoS Med Date: 2021-03-29 Impact factor: 11.069
Authors: Eva Hollemans; Esther I Verhoef; Chris H Bangma; John Rietbergen; Jozien Helleman; Monique J Roobol; Geert J L H van Leenders Journal: Mod Pathol Date: 2018-10-22 Impact factor: 7.842